Gleave ME - Search Results

1

Hiding in plain view: genetic profiling reveals decades old cross contamination of bladder cancer cell line KU7 with HeLa.

Jäger W, Horiguchi Y, Shah J, Hayashi T, Awrey S, Gust KM, Hadaschik BA, Matsui Y, Anderson S, Bell RH, Ettinger S, So AI, Gleave ME, Lee IL, Dinney CP, Tachibana M, McConkey DJ, Black PC. Jäger W, et al. Among authors: gleave me. J Urol. 2013 Oct;190(4):1404-9. doi: 10.1016/j.juro.2013.03.009. Epub 2013 Mar 7. J Urol. 2013. PMID: 23500642 Free PMC article.

2

Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer.

Gleave ME, Goldenberg SL, Jones EC, Bruchovsky N, Sullivan LD. Gleave ME, et al. J Urol. 1996 Jan;155(1):213-9. J Urol. 1996. PMID: 7490838 Clinical Trial.

3

Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer.

Gleave ME, Coupland D, Drachenberg D, Cohen L, Kwong S, Goldenberg SL, Sullivan LD. Gleave ME, et al. Urology. 1996 May;47(5):708-12. doi: 10.1016/s0090-4295(96)80016-1. Urology. 1996. PMID: 8650870

4

Inflammatory pseudotumor of the urinary bladder: a report of five cases and review of the literature.

Poon KS, Moreira O, Jones EC, Treissman S, Gleave ME. Poon KS, et al. Among authors: gleave me. Can J Urol. 2001 Dec;8(6):1409-15. Can J Urol. 2001. PMID: 11788019 Review.

5

Androgens and prostate cancer.

So AI, Hurtado-Coll A, Gleave ME. So AI, et al. Among authors: gleave me. World J Urol. 2003 Nov;21(5):325-37. doi: 10.1007/s00345-003-0373-9. Epub 2003 Oct 29. World J Urol. 2003. PMID: 14586548 Review.

6

Prostate specific antigen: an updated review.

So A, Goldenberg L, Gleave ME. So A, et al. Among authors: gleave me. Can J Urol. 2003 Dec;10(6):2040-50. Can J Urol. 2003. PMID: 14704108 Review.

7

Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence.

Ettinger SL, Sobel R, Whitmore TG, Akbari M, Bradley DR, Gleave ME, Nelson CC. Ettinger SL, et al. Among authors: gleave me. Cancer Res. 2004 Mar 15;64(6):2212-21. doi: 10.1158/0008-5472.can-2148-2. Cancer Res. 2004. PMID: 15026365

8

Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo.

July LV, Beraldi E, So A, Fazli L, Evans K, English JC, Gleave ME. July LV, et al. Among authors: gleave me. Mol Cancer Ther. 2004 Mar;3(3):223-32. Mol Cancer Ther. 2004. PMID: 15026542

9

YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity.

Giménez-Bonafé P, Fedoruk MN, Whitmore TG, Akbari M, Ralph JL, Ettinger S, Gleave ME, Nelson CC. Giménez-Bonafé P, et al. Among authors: gleave me. Prostate. 2004 May 15;59(3):337-49. doi: 10.1002/pros.20023. Prostate. 2004. PMID: 15042610

10

Effect of time of castration and tumour volume on time to androgen-independent recurrence in Shionogi tumours.

So AI, Bowden M, Gleave M. So AI, et al. BJU Int. 2004 Apr;93(6):845-50. doi: 10.1111/j.1464-410X.2003.04726.x. BJU Int. 2004. PMID: 15050003

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

667 results

Search Page

Filters